1. Home
  2. TSI vs EMBC Comparison

TSI vs EMBC Comparison

Compare TSI & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TCW Strategic Income Fund Inc.

TSI

TCW Strategic Income Fund Inc.

HOLD

Current Price

$4.46

Market Cap

215.2M

Sector

Finance

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$3.24

Market Cap

207.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSI
EMBC
Founded
1987
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
215.2M
207.1M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
TSI
EMBC
Price
$4.46
$3.24
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$18.50
AVG Volume (30 Days)
115.6K
2.5M
Earning Date
01-01-0001
05-05-2026
Dividend Yield
7.46%
6.88%
EPS Growth
N/A
20.90
EPS
N/A
0.67
Revenue
N/A
N/A
Revenue This Year
N/A
$1.17
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$4.75
Revenue Growth
N/A
N/A
52 Week Low
$4.43
$2.77
52 Week High
$5.06
$15.55

Technical Indicators

Market Signals
Indicator
TSI
EMBC
Relative Strength Index (RSI) 42.28 42.29
Support Level $4.43 $3.01
Resistance Level $4.58 $3.48
Average True Range (ATR) 0.03 0.17
MACD -0.00 0.08
Stochastic Oscillator 14.29 46.94

Price Performance

Historical Comparison
TSI
EMBC

About TSI TCW Strategic Income Fund Inc.

Tcw Strategic Income Fund Inc operates as a diversified closed-end management investment company. The investment objective of the company is to seek a total return comprised of current income and capital appreciation by investing in a wide range of securities. The company invests in a range of industries, such as banks, beverages, biotechnology, chemicals, commercial services, and others.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: